email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2986 - 3000
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Hua Medicine Completes $117 Million Funding for Novel Diabetes Treatment
$5.00
Available
Aslan Pharma of Singapore Files for $86 Million US IPO
$5.00
Available
Singlera Raises $60 Million in A+ Round for Cancer Tests
$5.00
Available
Adagene Completes $50 Million C Round for Oncology Clinical Trials
$5.00
Available
BI Forms $134 Million JV with Two China Partners for Foot-and-Mouth Vaccine
$5.00
Available
CBT Acquires Global Rights to CTLA-4 Checkpoint Inhibitor in $46 Million Deal
$5.00
Available
Simcere Partners with Agena for Companion Diagnostics in China
$5.00
Available
Fosun Acquires China Rights to Dove's Oral Thrombocytopenia Drug
$5.00
Available
China Accepts Chugai's NDA Submission for Novel Osteoporosis Treatment
$5.00
Available
Senju Acquires China-Japan Rights to Diabetic Macular Edema Treatment
$5.00
Available
Avita Medical Starts China Trial of "Spray-on Skin" for Burns
$5.00
Available
TCR2 Therapeutics Closes $125 Million B Round for Immunoncology Program
$5.00
Available
China Proposes to Eliminate Tax on Imported Cancer Drugs
$5.00
Available
Oxford Nanopore Completes $140 Million Funding Led by Asian Investors
$5.00
Available
CASI Raises $50 Million to Launch Drugs in China
$5.00
Available